within Pharmacolibrary.Drugs.ATC.N;

model N02AF01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00017166666666666667,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.305,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.277,
    k12             = 60.2,
    k21             = 60.2
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AF01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Butorphanol is a synthetic opioid analgesic used for the management of moderate to severe pain, including pain associated with surgery, migraine, and cancer. It acts primarily as an agonist-antagonist at opioid receptors (agonist at kappa and partial agonist/antagonist at mu receptors). Butorphanol is approved and currently used in both human and veterinary medicine, with formulations available for intravenous, intramuscular, and nasal administration.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Ebner, L, et al., &amp; Cox, S (2022). Pharmacokinetics of butorphanol following intravenous and intramuscular administration in donkeys: A preliminary study. <i>Frontiers in veterinary science</i> 9 979794–None. DOI:<a href=\"https://doi.org/10.3389/fvets.2022.979794\">10.3389/fvets.2022.979794</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36213418/\">https://pubmed.ncbi.nlm.nih.gov/36213418</a></p></li><li><p>Paine, SW, et al., &amp; Hillyer, L (2020). The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses. <i>Journal of veterinary pharmacology and therapeutics</i> 43(2) 162–170. DOI:<a href=\"https://doi.org/10.1111/jvp.12838\">10.1111/jvp.12838</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32012314/\">https://pubmed.ncbi.nlm.nih.gov/32012314</a></p></li><li><p>Berlin, ER, et al., &amp; Mama, KR (2023). Pharmacokinetics of intravenous propofol in southern white rhinoceros (Ceratotherium simum simum) after intramuscular etorphine-butorphanol-medetomidine-azaperone. <i>American journal of veterinary research</i> 84(4) –. DOI:<a href=\"https://doi.org/10.2460/ajvr.22.12.0224\">10.2460/ajvr.22.12.0224</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36812092/\">https://pubmed.ncbi.nlm.nih.gov/36812092</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AF01;
